Medical Affairs and Scientific Communications Forum

Market Access teams face increasing pressure to demonstrate value to payers. While therapeutic Medical Science Liaisons (MSLs) play a vital role in advancing scientific understanding with clinicians, payer engagement benefits from field medical partners whose remit is to translate evidence for access decision-makers. Payers seek scientific dialogue that bridges clinical, economic, and real-world evidence to access considerations, an area well served by specialized field medical experts such as Managed Care Liaisons (MCLs), Health Outcomes Liaisons (HOLs), and other similarly titled field medical personnel designated to support Market Access.

For Medical Affairs leaders, this is a pivotal and often under leveraged opportunity. By strategically aligning with Market Access colleagues, Medical Affairs can strengthen credibility, accelerate access, and fill genuine business needs, all while operating compliantly across the “firewall.” This session explores how forward-thinking Medical Affairs organizations are redefining their field strategies to bridge science and access, elevate payer engagement, and become indispensable partners to their Market Access counterparts.

Through case examples, panel dialogue, and decades of field experience, participants will learn how to evolve their Medical Affairs field model to deliver both scientific excellence and tangible access impact.

At the conclusion of this session, participants should be able to:

• Differentiate between therapeutic MSLs and payer-facing field medical roles in purpose, execution, and impact
• Recognize the strategic opportunity for Medical Affairs to partner with Market Access through compliant collaboration that advances payer engagement and evidence translation.
• Illustrate real-world examples of successful cross-functional partnership between Medical Affairs, Health Economics and Outcomes Research (HEOR), and Market Access that improved payer engagement.